Science Explorer Back to mapMap
Discussion
Researcher · Holy Cross University · Poland

Jolanta Smok-Kalwat

Jolanta Smok-Kalwat publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies and Cancer Treatment and Pharmacology.

ORCID 0000-0003-3134-5207 OpenAlex
World rank
#1,906,909
of 7,710,434 ranked researchers
Rank in Poland
#11,399
of 100,960
Works
54
Citations
1k
Citations per work
18.7
h-index
16
i10-index 21Top 33% in Oncology
Jolanta Smok-Kalwat

What does Jolanta Smok-Kalwat research?

Jolanta Smok-Kalwat's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (7%).

Health Sciences: 23 works · 42.1% of their workMedicine: 23 works · 42.1% of their workOncology: 15 works · 27.0% of their workPulmonary and Respiratory Medicine: 6 works · 11.3% of their workEpidemiology: 2 works · 3.8% of their workEverything else: 21 works · 38.4% of their workLife Sciences: 11 works · 19.5% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 12.6% of their workMolecular Biology: 4 works · 6.9% of their workCancer Research: 3 works · 5.7% of their workImmunology and Microbiology: 4 works · 6.9% of their workImmunology: 4 works · 6.9% of their workTHEIR WORKJolantaSmok-Kalwat54works
Life Sciences20%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2342.1%
  2. Everything else2138.4%
    1. Biochemistry, Genetics and Molecular Biology712.6%
    2. Immunology and Microbiology46.9%
  1. 1Oncology27% of their works
  2. 2Pulmonary and Respiratory Medicine11% of their works
  3. 3Immunology7% of their works
  4. 4Molecular Biology7% of their works
  5. 5Cancer Research6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Jolanta Smok-Kalwat's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Breast Tumours, Chemotherapy-Induced Peripheral Neuropathy, Gene Expression and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Breast Cancer152 topics
  2. Metastatic Breast Cancer152 topics
  3. CDK4/6 Inhibitors81 topic
  4. Palbociclib81 topic
  5. Breast Tumours71 topic
  6. Chemotherapy-Induced Peripheral Neuropathy71 topic
  7. Gene Expression71 topic
  8. HER271 topic
  9. Taxanes71 topic
  10. Trastuzumab71 topic
  11. Immune Checkpoint Blockade61 topic
  12. PD-1 and PD-L161 topic
  13. Chronic Lymphocytic Leukemia51 topic
  14. Genomic Aberrations51 topic
  15. Cancer Incidence41 topic
  16. Genetic Mutations41 topic
  17. Mortality Rates41 topic
  18. Primary Immunodeficiency41 topic

Where does Jolanta Smok-Kalwat work?

Jolanta Smok-Kalwat's main affiliation in the publication record is Holy Cross University, Poland.

How many publications and citations does Jolanta Smok-Kalwat have?

OpenAlex counts 54 works and 1,009 citations for Jolanta Smok-Kalwat, an h-index of 16, ranking #1,906,909 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jolanta Smok-Kalwat. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.